← Back to Dictionary
Fat Loss
Tirzepatide
Molecular Weight
4813.45 Da
Half-Life
~5 days
Dosing Protocol
2.5-15 mg subcutaneous weekly, titrated
Key Benefits
Significant weight reductionImproved glycemic controlCardiovascular markers improvementAppetite regulation
Mechanism of Action
Dual GIP/GLP-1 receptor agonist. Enhances insulin secretion, suppresses glucagon, slows gastric emptying, promotes satiety.
Research Summary
FDA-approved with Phase 3 trials showing up to 22.5% body weight reduction and significant HbA1c improvement.
Stacks Well With